7 research outputs found

    Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants - Fig 2

    No full text
    <p><b>Comparison of the quantification of minority resistant variants (MRV) using SmartGene<sup>®</sup> (SG) and Geneious<sup>®</sup> pipeline analysis for protease mutations (A, B), Reverse Transcriptase (RT) (C, D) and integrase mutations (E, F).</b> Minority resistant variants frequencies were depicted according to linear regression (A, C, E) and Bland-Altman (B, D, F) analyses. For Bland-Altman analysis, y-axis indicates the percentage of difference in MRV frequency measurements between Geneouis<sup>®</sup> and SG<sup>®</sup> analysis and x-axis indicates the mean of the two measurements. All MRV detected by both software were included in this analysis. The 95% confidence interval limits of agreement were calculated. Mean, upper and lower limits of agreement were depicted by the dotted lines.</p

    Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants - Fig 1

    No full text
    <p><b>Comparison of the quantification of minority resistant variants (MRV) using SmartGene<sup>®</sup> (SG) and AVA<sup>®</sup> pipeline analysis for protease mutations (A,B) and Reverse Transcriptase (RT) (C, D) mutations after excluding two major discrepancies</b>. Minority resistant variants frequencies were depicted according to linear regression (A, C) and Bland-Altman (B, D) analyses. For Bland-Altman analysis, y-axis indicates the percentage of difference in MRV frequency measurements between AVA<sup>®</sup> and SG<sup>®</sup> analysis and x-axis indicates the mean of the two measurements. All MRV detected by both software were included in this analysis. The 95% confidence intervals limits of agreement were calculated. Mean, upper and lower limits of agreement were depicted by the dotted lines.</p
    corecore